Goldman Sachs initiates coverage on Portola Pharmaceuticals (NASDAQ:PTLA) with a Neutral rating.
Goldman Sachs Initiates Coverage On Portola Pharmaceuticals with Neutral Rating
Goldman Sachs initiates coverage on Portola Pharmaceuticals (NASDAQ:PTLA) with a Neutral rating.
Benzinga · 11/08/2019 11:36